Venture Capital

Updated:

DaVita Venture Group

DaVita Venture Group invests in, acquires, and co-develops products and solutions for kidney disease and related conditions. Its portfolio includes care...

DaVita Venture Group logo

DaVita Venture Group

DaVita Venture Group invests in, acquires, and co-develops products and solutions for kidney disease and related conditions. Its portfolio includes care delivery models, life sciences advancements, and digital health technologies. The company was founded in 2020 in Denver, Colorado.

General information

Firm type

Venture Capital

Year founded

2019

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Denver

Corporate office

Denver, United States

Sector focus

Private Equity

Frequently asked questions

Who runs investment decisions at DaVita Venture Group?

No named principals or investment committee members are identified in available records.

Does DaVita Venture Group participate in fund commitments or only direct deals?

Source material provides no detail on fund commitments versus direct investments.

What investment stages does DaVita Venture Group typically target?

The firm targets early stage seed, start-up, and growth opportunities.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Denver Venture Capital profiles